ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer
Go back to ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer| (NASDAQ: IBRX) | Delayed: 8.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.64 | 52 Week High | $ | |||
| Open | $8.64 | 52 Week Low | $ | |||
| Day High | $8.64 | P/E | N/A | |||
| Day Low | $8.64 | EPS | $ | |||
| Volume | 3,064 | |||||



